6/16/2006 - Seven scientists from Vanderbilt University Medical Center will discuss their research at the biennial meeting of the world's largest neuropsychopharmacology organization July 9-13 in Chicago.
An estimated 4,000 psychiatrists, scientists and mental health officials from 30 countries are expected to attend the 25th Congress of the Collegium Internationale Neuro-Psychopharmocologicum (CINP).
Vanderbilt's Herbert Meltzer, M.D., former CINP president, chairs the national organizing committee for the meeting. Meltzer, who is one of the world's leading authorities on the treatment of schizophrenia and the prevention of suicide in patients with the disease, will discuss the latest research on the action of antipsychotic drugs and guidelines for schizophrenia treatment.
Meltzer is the Bixler/May/Johnson Professor of Psychiatry, director of the Division of Psychopharmacology and professor of Pharmacology at Vanderbilt.
Other Vanderbilt speakers include: P. Jeffrey Conn, Ph.D., professor of Pharmacology, director of that department's Program in Translational Neuropharmacology, and director of the Vanderbilt Institute of Chemical Biology's drug discovery program; Robert Kessler, M.D., Roentgen Professor of Radiology and Radiological Sciences and director of the Center for Molecular Imaging at Vanderbilt; Patrizia Riccardi, M.D., research assistant professor of Radiology and Radiological Sciences; Ronald Salomon, M.D., associate professor of Psychiatry; Richard Shelton, M.D., professor of Psychiatry and Pharmacology and director of the Division of Adult Psychiatry; and Monsheel Sodhi, Ph.D., research assistant professor of Psychiatry.
For more information about the meeting, visit the CINP Web site at www.cinp2006.com <http://www.cinp2006.com/> or contact CINP Executive Director Oakley Ray, Ph.D., professor of Psychology, emeritus, at firstname.lastname@example.org.©2017 Vanderbilt University Medical Center